To evaluate the role of miR-138-1-3p and PAK5 in HCC sorafenib resistance in vivo, xenograft cancer models were established by subcutaneously inoculating HepG2-SR cells. The gene discussed is PAK5; the disease is hepatocellular carcinoma.